measuregroup/AID86066

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103207624_AID86066_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103207963_AID86066_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103207559_AID86066_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103207964_AID86066_PMID_VALUE5 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID103207530_AID86066_PMID_VALUE1 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID123097261_AID86066_PMID_VALUE6
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/cell/CELLID298
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title	Compound was tested in vitro to inhibit 50% colon carcinoma HT-29 cell growth after 72 h
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103207624 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103207964 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103207530 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID123097261 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103207963 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID103207559
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID86066

Total number of triples: 17.